RX Accunet Embolic Protection System
Temporary Carotid Catheter For Embolic Capture. 510(k) K052165, from Guidant Corporation (Santa Clara, CA). Product code NTE, class 2.
As of Nov 20, 2026, K052165 is an FDA 510(k) held by Guidant Corporation, substantially equivalent on Aug 16, 2005 after 7 days, with no recalls tied to it in FDA's recall database.
- Review time: 7 days
- Recalls: 0
- Cited as a predicate by: 1 device
evice Name RX ACCUNET™ Embolic Protection System Indications for Use The RX ACCUNET™ Embolic Protection System is indicated for use as a guide wire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries.
- Accunet Embolic Protection System, RX Accunet Embolic Protection SystemK042218 · Guidant Corp. · Aug 31, 2004
- K024418K024418
- RX Accunet 2 Embolic Protection SystemK042908 · Guidant Corp. · Nov 12, 2004
- RX Accunet LP Embolic Protection SystemK081549 · Abbott Laboratories · Aug 19, 2008
- Neuroguard IEP Embolic Protection SystemK260600 · Contego Medical, Inc. · Nov 4, 2026
- EmPro EPS (EP4514C-190, EP6514C-190);Nanoparasol EPS (PNP4514C-190,PNP6514C-190)K222694 · MicroVention, Inc. · Apr 27, 2023
- ENROUTE® Transcarotid Neuroprotection SystemK230402 · Silk Road Medical · Apr 11, 2023
- ANGIOGUARD XP Emboli Capture Guidewire, ANGIOGUARD RX Emboli Capture GuidewireK220654 · Cordis Corporation · Apr 6, 2022
- WIRION Embolic Protection SystemK210282 · Cardiovascular Systems, Inc. · Mar 3, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Aug 9, 2005
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files